1 results match your criteria: "MA (E.F.C.). mmaron@tuftsmedicalcenter.org.[Affiliation]"
Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy.
Circulation
August 2014
From the PERFUSE Study Group, Harvard Medical School, Boston, MA (R.H.C., S.N.H., C.M.B., W.J.M., E.A.); Department of Medicine, Cardiovascular Division, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA (R.H.C., S.N.H., C.M.B., W.J.M., E.A.); Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, Minneapolis, MN (B.J.M., T.H., J.R.L.); Referral Center for Myocardial Diseases, Azienda Ospedaliera Universitaria Careggi, Florence Italy (I.O., F.C., B.T.); Harvard Clinical Research Institute and Boston University Biostatistics, Boston, MA (M.J.P.); Ospedale Sant'Andrea Universita "La Sapienza," Rome, Italy (G.E.A., C.N.D.C., C.A.); Division of Cardiology, Toronto General Hospital, University Health Network, University of Toronto, Toronto, ON, Canada (C.G., A.M.C., H.R.); Hypertrophic Cardiomyopathy Center, Division of Cardiology, Tufts Medical Center, Boston, MA (J.E.U., E.R., M.S.M.); Fondazione C.N.R./Regione Toscana G. Monasterio, Pisa, Italy (M.L.); Ente Ospedaliero Ospedali Galliera, Genoa, Italy (P.S., F.F.); Policlinico S. Orsola-Malpighi, Bologna, Italy (E.B., C.R.); and Department of Epidemiology, Harvard School of Public Health, Boston, MA (E.F.C.).
Background: Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden death in the young, although not all patients eligible for sudden death prevention with an implantable cardioverter-defibrillator are identified. Contrast-enhanced cardiovascular magnetic resonance with late gadolinium enhancement (LGE) has emerged as an in vivo marker of myocardial fibrosis, although its role in stratifying sudden death risk in subgroups of HCM patients remains incompletely understood.
Methods And Results: We assessed the relation between LGE and cardiovascular outcomes in 1293 HCM patients referred for cardiovascular magnetic resonance and followed up for a median of 3.